|
1
|
DeSantis C, Ma J, Bryan L and Jemal A:
Breast cancer statistics, 2013. CA Cancer J Clin. 64:52–62. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
McGuire S: World Cancer Report 2014.
Geneva, Switzerland: World Health Organization, International
agency for research on cancer, WHO Press, 2015. Adv Nutr.
7:418–419. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fan L, Strasser-Weippl K, Li JJ, St Louis
J, Finkelstein DM, Yu KD, Chen WQ, Shao ZM and Goss PE: Breast
cancer in China. Lancet Oncol. 15:e279–e289. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dickens C, Joffe M, Jacobson J, Venter F,
Schüz J, Cubasch H and McCormack V: Stage at breast cancer
diagnosis and distance from diagnostic hospital in a periurban
setting: A South African public hospital case series of over 1,000
women. Int J Cancer. 135:2173–2182. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Narod SA, Iqbal J, Giannakeas V, Sopik V
and Sun P: Breast cancer mortality after a diagnosis of ductal
carcinoma in situ. JAMA Oncol. 1:888–896. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xia M, Li H, Wang JJ, Zeng HJ and Wang SH:
MiR-99a suppress proliferation, migration and invasion through
regulating insulin-like growth factor 1 receptor in breast cancer.
Eur Rev Med Pharmacol Sci. 20:1755–1763. 2016.PubMed/NCBI
|
|
7
|
Calin GA, Sevignani C, Dumitru CD, Hyslop
T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M
and Croce CM: Human microRNA genes are frequently located at
fragile sites and genomic regions involved in cancers. Proc Natl
Acad Sci USA. 101:2999–3004. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rathod SS, Rani SB, Khan M, Muzumdar D and
Shiras A: Tumor suppressive miRNA-34a suppresses cell proliferation
and tumor growth of glioma stem cells by targeting Akt and Wnt
signaling pathways. FEBS Open Bio. 4:485–495. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li XT, Wang HZ, Wu ZW, Yang TQ, Zhao ZH,
Chen GL, Xie XS, Li B, Wei YX, Huang YL, et al: miR-494-3p
regulates cellular proliferation, invasion, migration, and
apoptosis by PTEN/AKT signaling in human glioblastoma cells. Cell
Mol Neurobiol. 35:679–687. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ozen M, Creighton CJ, Ozdemir M and
Ittmann M: Widespread deregulation of microRNA expression in human
prostate cancer. Oncogene. 27:1788–1793. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Volinia S, Calin GA, Liu CG, Ambs S,
Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et
al: A microRNA expression signature of human solid tumors defines
cancer gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu H, Wang Y, Li X, Zhang YJ, Li J, Zheng
YQ, Liu M, Song X and Li XR: Expression and regulatory function of
miRNA-182 in triple-negative breast cancer cells through its
targeting of profilin 1. Tumour Biol. 34:1713–1722. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sestito R, Cianfrocca R, Rosanò L, Tocci
P, Semprucci E, Di Castro V, Caprara V, Ferrandian G, Sacconi A,
Blandino G and Bagnato A: MiR-30a inhibits endothelin A receptor
and chemoresistance in ovarian carcinoma. Oncotarget. 7:4009–4023.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tang R, Liang L, Luo DZ, Feng ZB, Huang
QX, He RQ, Gan TQ, Yang LH and Chen G: Downregulation of MiR-30a is
associated with poor prognosis in lung cancer. Med Sci Monit.
21:2514–2520. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang W, Lin H, Zhou L, Zhu Q, Gao S, Xie
H, Liu Z, Xu Z, Wei J, Huang X and Zheng S: MicroRNA-30a-3p
inhibits tumor proliferation, invasiveness and metastasis and is
downregulated in hepatocellular carcinoma. Eur J Surg Oncol.
40:1586–1594. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang LL, Zhang XH, Zhang X and Chu JK:
MiR-30a increases cisplatin sensitivity of gastric cancer cells
through suppressing epithelial-to-mesenchymal transition (EMT). Eur
Rev Med Pharmacol Sci. 20:1733–1739. 2016.PubMed/NCBI
|
|
17
|
Liu Z, Tu K and Liu Q: Effects of
microRNA-30a on migration, invasion and prognosis of hepatocellular
carcinoma. FEBS Lett. 588:3089–3097. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu Z, Chen L, Zhang X, Xu X, Xing H,
Zhang Y, Li W, Yu H, Zeng J and Jia J: RUNX3 regulates vimentin
expression via miR-30a during epithelial-mesenchymal transition in
gastric cancer cells. J Cell Mol Med. 18:610–623. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang Y, Li SJ, Pan J, Che Y, Yin J and
Zhao Q: Specific expression of the human voltage-gated proton
channel Hv1 in highly metastatic breast cancer cells, promotes
tumor progression and metastasis. Biochem Biophys Res Commun.
412:353–359. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu F, Liu Y, Shen J, Zhang G and Han J:
MicroRNA-224 inhibits proliferation and migration of breast cancer
cells by down-regulating fizzled 5 expression. Oncotarget.
7:49130–49142. 2016.PubMed/NCBI
|
|
21
|
Kuang Y and Nie YJ: Exploration of the
regulatory effect of miR-21 on breast cancer cell line
proliferation and invasion as well as the downstream target genes.
Asian Pac J Trop Med. 9:470–473. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yu J, Wang JG, Zhang L, Yang HP, Wang L,
Ding D, Chen Q, Yang WL, Ren KH, Zhou DM, et al: MicroRNA-320a
inhibits breast cancer metastasis by targeting metadherin.
Oncotarget. 7:38612–38625. 2016.PubMed/NCBI
|
|
23
|
Yan LX, Huang XF, Shao Q, Huang MY, Deng
L, Wu QL, Zeng YX and Shao JY: MicroRNA miR-21 overexpression in
human breast cancer is associated with advanced clinical stage,
lymph node metastasis and patient poor prognosis. RNA.
14:2348–2360. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yan LX, Wu QN, Zhang Y, Li YY, Liao DZ,
Hou JH, Fu J, Zeng MS, Yun JP, Wu QL, et al: Knockdown of miR-21 in
human breast cancer cell lines inhibits proliferation, in vitro
migration and in vivo tumor growth. Breast Cancer Res. 13:R22011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Crow MS, Lum KK, Sheng X, Song B and
Cristea IM: Diverse mechanisms evolved by DNA viruses to inhibit
early host defenses. Crit Rev Biochem Mol Biol. 51:452–481. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Qi J, Li T, Bian H, Li F, Ju Y, Gao S, Su
J, Ren W and Qin C: SNAI1 promotes the development of HCC through
the enhancement of proliferation and inhibition of apoptosis. FEBS
Open Bio. 6:326–337. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang L, Wang YJ, Zheng LY, Jia YM, Chen
YL, Chen L, Liu DG, Li XH, Guo HY, Sun YL, et al: Genetic
polymorphisms of TGFB1, TGFBR1, SNAI1 and TWIST1 are associated
with endometrial cancer susceptibility in Chinese Han women. PLoS
One. 11:e01552702016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Haraguchi M, Sato M and Ozawa M:
CRISPR/Cas9n-mediated deletion of the Snail 1Gene (SNAI1) reveals
its role in regulating cell morphology, cell-cell interactions, and
gene expression in ovarian cancer (RMG-1) cells. PLoS One.
10:e01322602015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bai Z, Sun J, Wang X, Wang H, Pei H and
Zhang Z: MicroRNA-153 is a prognostic marker and inhibits cell
migration and invasion by targeting SNAI1 in human pancreatic
ductal adenocarcinoma. Oncol Rep. 34:595–602. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang Y, Shi J, Chai K, Ying X and Zhou BP:
The role of Snail in EMT and tumorigenesis. Curr Cancer Drug
Targets. 13:963–972. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kaufhold S and Bonavida B: Central role of
Snail1 in the regulation of EMT and resistance in cancer: A target
for therapeutic intervention. J Exp Clin Cancer Res. 33:622014.
View Article : Google Scholar : PubMed/NCBI
|
